Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Bexarotene (Targretin) Capsules With Tretinoin and Chemotherapy in Patients With Advanced Non-small-cell Lung Cancer

NCT00514293 is registered in ClinicalTrials.gov with Raghu Nandan, M.D., Inc as lead sponsor.

NCT NCT00514293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00514293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Bexarotene (Targretin) Capsules With Tretinoin and Chemotherapy in Patients With Advanced Non-small-cell Lung Cancer
Lead sponsor
Raghu Nandan, M.D., Inc
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2007
Completion date
Not reported
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer